183 related articles for article (PubMed ID: 19812561)
1. CCL3L1 and HIV/AIDS susceptibility.
Bhattacharya T; Stanton J; Kim EY; Kunstman KJ; Phair JP; Jacobson LP; Wolinsky SM
Nat Med; 2009 Oct; 15(10):1112-5. PubMed ID: 19812561
[No Abstract] [Full Text] [Related]
2. CCL3L1 and HIV/AIDS susceptibility.
Urban TJ; Weintrob AC; Fellay J; Colombo S; Shianna KV; Gumbs C; Rotger M; Pelak K; Dang KK; Detels R; Martinson JJ; O'Brien SJ; Letvin NL; McMichael AJ; Haynes BF; Carrington M; Telenti A; Michael NL; Goldstein DB
Nat Med; 2009 Oct; 15(10):1110-2. PubMed ID: 19812560
[No Abstract] [Full Text] [Related]
3. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Gonzalez E; Kulkarni H; Bolivar H; Mangano A; Sanchez R; Catano G; Nibbs RJ; Freedman BI; Quinones MP; Bamshad MJ; Murthy KK; Rovin BH; Bradley W; Clark RA; Anderson SA; O'connell RJ; Agan BK; Ahuja SS; Bologna R; Sen L; Dolan MJ; Ahuja SK
Science; 2005 Mar; 307(5714):1434-40. PubMed ID: 15637236
[TBL] [Abstract][Full Text] [Related]
4. HIV/AIDS. HIV: experiencing the pressures of modern life.
Nolan D; James I; Mallal S
Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
[No Abstract] [Full Text] [Related]
5. Gene copy number: learning to count past two.
Shrestha S; Tang J; Kaslow RA
Nat Med; 2009 Oct; 15(10):1127-9. PubMed ID: 19812568
[No Abstract] [Full Text] [Related]
6. Experimental aspects of copy number variant assays at CCL3L1.
Field SF; Howson JM; Maier LM; Walker S; Walker NM; Smyth DJ; Armour JA; Clayton DG; Todd JA
Nat Med; 2009 Oct; 15(10):1115-7. PubMed ID: 19812562
[No Abstract] [Full Text] [Related]
7. CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.
Kulkarni H; Agan BK; Marconi VC; O'Connell RJ; Camargo JF; He W; Delmar J; Phelps KR; Crawford G; Clark RA; Dolan MJ; Ahuja SK
PLoS One; 2008 Sep; 3(9):e3165. PubMed ID: 18776933
[TBL] [Abstract][Full Text] [Related]
8. Reply to: "Experimental aspects of copy number variant assays at CCL3L1".
He W; Kulkarni H; Castiblanco J; Shimizu C; Aluyen U; Maldonado R; Carrillo A; Griffin M; Lipsitt A; Beachy L; Shostakovich-Koretskaya L; Mangano A; Sen L; Nibbs RJ; Tiemessen CT; Bolivar H; Bamshad MJ; Clark RA; Burns JC; Dolan MJ; Ahuja SK
Nat Med; 2009 Oct; 15(10):1117-20. PubMed ID: 19812563
[No Abstract] [Full Text] [Related]
9. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
Dolan MJ; Kulkarni H; Camargo JF; He W; Smith A; Anaya JM; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RA; Anderson SA; Delmar J; O'Connell RJ; Lloyd A; Martin J; Ahuja SS; Agan BK; Walker BD; Deeks SG; Ahuja SK
Nat Immunol; 2007 Dec; 8(12):1324-36. PubMed ID: 17952079
[TBL] [Abstract][Full Text] [Related]
10. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
[TBL] [Abstract][Full Text] [Related]
11. CCL3L1 dose and HIV-1 susceptibility.
Mackay CR
Trends Mol Med; 2005 May; 11(5):203-6. PubMed ID: 15882607
[TBL] [Abstract][Full Text] [Related]
12. HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.
Nakajima T; Kaur G; Mehra N; Kimura A
Cytogenet Genome Res; 2008; 123(1-4):156-60. PubMed ID: 19287150
[TBL] [Abstract][Full Text] [Related]
13. Population-specific profiling of CCL3L1 copy number of the three major ethnic groups in Malaysia and the implication on HIV susceptibility.
Mohamad Isa II; Jamaluddin J; Achim NH; Abubakar S
Gene; 2020 Sep; 754():144821. PubMed ID: 32497559
[TBL] [Abstract][Full Text] [Related]
14. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
Ahuja SK; Kulkarni H; Catano G; Agan BK; Camargo JF; He W; O'Connell RJ; Marconi VC; Delmar J; Eron J; Clark RA; Frost S; Martin J; Ahuja SS; Deeks SG; Little S; Richman D; Hecht FM; Dolan MJ
Nat Med; 2008 Apr; 14(4):413-20. PubMed ID: 18376407
[TBL] [Abstract][Full Text] [Related]
15. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
Gonzalez E; Dhanda R; Bamshad M; Mummidi S; Geevarghese R; Catano G; Anderson SA; Walter EA; Stephan KT; Hammer MF; Mangano A; Sen L; Clark RA; Ahuja SS; Dolan MJ; Ahuja SK
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5199-204. PubMed ID: 11320252
[TBL] [Abstract][Full Text] [Related]
16. Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population.
Mamtani M; Mummidi S; Ramsuran V; Pham MH; Maldonado R; Begum K; Valera MS; Sanchez R; Castiblanco J; Kulkarni H; Ndung'u T; He W; Anaya JM; Ahuja SK
J Infect Dis; 2011 Jun; 203(11):1590-4. PubMed ID: 21592988
[TBL] [Abstract][Full Text] [Related]
17. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
Hendel H; Hénon N; Lebuanec H; Lachgar A; Poncelet H; Caillat-Zucman S; Winkler CA; Smith MW; Kenefic L; O'Brien S; Lu W; Andrieu JM; Zagury D; Schächter F; Rappaport J; Zagury JF
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):381-6. PubMed ID: 9833747
[TBL] [Abstract][Full Text] [Related]
18. CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.
Aklillu E; Odenthal-Hesse L; Bowdrey J; Habtewold A; Ngaimisi E; Yimer G; Amogne W; Mugusi S; Minzi O; Makonnen E; Janabi M; Mugusi F; Aderaye G; Hardwick R; Fu B; Viskaduraki M; Yang F; Hollox EJ
BMC Infect Dis; 2013 Nov; 13():536. PubMed ID: 24219137
[TBL] [Abstract][Full Text] [Related]
19. The impact of CCL3L1 copy number in an HIV-1-infected white population.
Lee EY; Yue FY; Jones RB; Lo C; Sheth P; Hyrcza MD; Kovacs C; Benko E; Kaul R; Ostrowski M
AIDS; 2010 Jun; 24(10):1589-91. PubMed ID: 20442635
[TBL] [Abstract][Full Text] [Related]
20. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
Gonzalez E; Bamshad M; Sato N; Mummidi S; Dhanda R; Catano G; Cabrera S; McBride M; Cao XH; Merrill G; O'Connell P; Bowden DW; Freedman BI; Anderson SA; Walter EA; Evans JS; Stephan KT; Clark RA; Tyagi S; Ahuja SS; Dolan MJ; Ahuja SK
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12004-9. PubMed ID: 10518566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
